| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 5 | 0 | 0 | 5 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| acid sphingomyelinase | 4 | 0 | 0 | 4 |
| thioredoxin reductase | 12 | 0 | 0 | 12 |
| USP1 protein, partial | 14 | 0 | 0 | 14 |
| TDP1 protein | 34 | 0 | 0 | 34 |
| vitamin D3 receptor isoform VDRA | 12 | 0 | 0 | 12 |
| importin subunit beta-1 isoform 1 | 5 | 0 | 0 | 5 |
| flap endonuclease 1 | 8 | 0 | 0 | 8 |
| serine/threonine-protein kinase PLK1 | 3 | 0 | 0 | 3 |
| snurportin-1 | 5 | 0 | 0 | 5 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 5 | 0 | 0 | 5 |
| GTP-binding nuclear protein Ran isoform 1 | 3 | 0 | 0 | 3 |
| DNA polymerase eta isoform 1 | 6 | 0 | 0 | 6 |
| DNA polymerase iota isoform a (long) | 12 | 0 | 0 | 12 |
| urokinase-type plasminogen activator precursor | 5 | 0 | 0 | 5 |
| plasminogen precursor | 5 | 0 | 0 | 5 |
| urokinase plasminogen activator surface receptor precursor | 5 | 0 | 0 | 5 |
| geminin | 25 | 0 | 0 | 25 |
| DNA polymerase kappa isoform 1 | 15 | 0 | 0 | 15 |
| fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
| Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Transthyretin | 0 | 1 | 3 | 4 |
| Fatty acid-binding protein, intestinal | 0 | 1 | 1 | 2 |
| Fatty acid-binding protein, adipocyte | 0 | 2 | 2 | 4 |
| Cyclin-A2 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 2 | 0 | 2 | 1 | 3 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
| Fatty acid-binding protein 5 | 0 | 1 | 1 | 2 |
| Fatty acid-binding protein 5 | 0 | 0 | 2 | 2 |
| Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| estrogen-related nuclear receptor alpha | 29 | 0 | 0 | 29 |
| hypoxia-inducible factor 1 alpha subunit | 9 | 0 | 0 | 9 |
| RAR-related orphan receptor gamma | 22 | 0 | 0 | 22 |
| GLI family zinc finger 3 | 21 | 0 | 0 | 21 |
| AR protein | 34 | 0 | 0 | 34 |
| aldehyde dehydrogenase 1 family, member A1 | 16 | 0 | 0 | 16 |
| retinoic acid nuclear receptor alpha variant 1 | 20 | 0 | 0 | 20 |
| retinoid X nuclear receptor alpha | 18 | 0 | 0 | 18 |
| estrogen nuclear receptor alpha | 39 | 0 | 0 | 39 |
| peroxisome proliferator-activated receptor delta | 16 | 0 | 0 | 16 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 15 | 0 | 0 | 15 |
| activating transcription factor 6 | 9 | 0 | 0 | 9 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 12 | 0 | 0 | 12 |
| Histone H2A.x | 11 | 0 | 0 | 11 |
| thyroid hormone receptor beta isoform a | 9 | 0 | 0 | 9 |
| heat shock protein beta-1 | 8 | 0 | 0 | 8 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 22 | 0 | 0 | 22 |
| lamin isoform A-delta10 | 22 | 0 | 0 | 22 |
| Voltage-dependent calcium channel gamma-2 subunit | 12 | 0 | 0 | 12 |
| Glutamate receptor 2 | 13 | 0 | 0 | 13 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 15 | 0 | 0 | 15 |
| Chain A, 2-oxoglutarate Oxygenase | 14 | 0 | 0 | 14 |
| glp-1 receptor, partial | 6 | 0 | 0 | 6 |
| Smad3 | 7 | 0 | 0 | 7 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| cellular tumor antigen p53 isoform a | 8 | 0 | 0 | 8 |
| mitogen-activated protein kinase 1 | 10 | 0 | 0 | 10 |
| nuclear receptor ROR-gamma isoform 1 | 9 | 0 | 0 | 9 |
| cytochrome P450 3A4 isoform 1 | 13 | 0 | 0 | 13 |
| Gamma-aminobutyric acid receptor subunit pi | 13 | 4 | 1 | 18 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 7 | 2 | 0 | 9 |
| Carbonic anhydrase 12 | 0 | 4 | 0 | 5 |
| Carbonic anhydrase 1 | 0 | 10 | 0 | 12 |
| Carbonic anhydrase 2 | 0 | 11 | 0 | 13 |
| Integrin beta-3 | 6 | 1 | 0 | 7 |
| ATP-dependent translocase ABCB1 | 0 | 8 | 1 | 13 |
| Integrin alpha-IIb | 6 | 1 | 0 | 7 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| Pyruvate kinase PKM | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 13 | 4 | 1 | 18 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | 13 | 4 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 13 | 4 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 13 | 4 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 13 | 4 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 13 | 4 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 13 | 4 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 13 | 4 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 13 | 4 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 13 | 4 | 1 | 18 |
| Histamine H2 receptor | 11 | 0 | 0 | 11 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 13 | 5 | 1 | 19 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 13 | 4 | 1 | 18 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 13 | 4 | 1 | 18 |
| Cytochrome P450 1B1 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 9 | 0 | 5 | 0 | 6 |
| GABA theta subunit | 13 | 4 | 1 | 18 |
| Aurora kinase B | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit epsilon | 13 | 4 | 1 | 18 |
| Dipeptidyl peptidase 3 | 0 | 2 | 0 | 2 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 3 | 14 | 0 | 0 | 14 |
| pregnane X nuclear receptor | 22 | 0 | 0 | 22 |
| glucocorticoid receptor [Homo sapiens] | 25 | 0 | 0 | 25 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 10 | 0 | 0 | 10 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Mineralocorticoid receptor | 0 | 3 | 3 | 6 |
| Androgen receptor | 0 | 6 | 0 | 6 |
| Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 2 |
| Chitinase B | 0 | 6 | 2 | 8 |
| Endochitinase | 0 | 1 | 0 | 1 |
| Endochitinase A1 | 0 | 2 | 0 | 2 |
| Acidic mammalian chitinase | 0 | 2 | 0 | 2 |
| peripheral myelin protein 22 | 8 | 0 | 0 | 8 |
| histone acetyltransferase KAT2A isoform 1 | 11 | 0 | 0 | 11 |
| ATP-binding cassette sub-family C member 3 | 0 | 30 | 0 | 30 |
| Multidrug resistance-associated protein 4 | 0 | 30 | 0 | 31 |
| Bile salt export pump | 0 | 39 | 0 | 39 |
| Canalicular multispecific organic anion transporter 1 | 0 | 30 | 0 | 31 |
| Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 1 |
| ATP-dependent phosphofructokinase | 8 | 0 | 0 | 8 |
| Chain A, HADH2 protein | 12 | 0 | 0 | 12 |
| Chain B, HADH2 protein | 12 | 0 | 0 | 12 |
| Chain A, Cruzipain | 7 | 0 | 0 | 7 |
| interleukin 8 | 7 | 0 | 0 | 7 |
| phosphopantetheinyl transferase | 10 | 0 | 0 | 10 |
| GLS protein | 12 | 0 | 0 | 12 |
| farnesoid X nuclear receptor | 12 | 0 | 0 | 12 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 17 | 0 | 0 | 17 |
| tumor necrosis factor | 2 | 0 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 3 | 0 | 3 |
| Cytochrome P450 3A4 | 0 | 12 | 1 | 13 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 11 | 0 | 11 |
| Cytochrome P450 2C19 | 0 | 4 | 0 | 4 |
| Nuclear receptor ROR-gamma | 8 | 0 | 0 | 8 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 13 | 0 | 15 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 3 |
| Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 6 | 0 | 0 | 6 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 5 | 0 | 0 | 5 |
| Beta-lactamase | 0 | 4 | 0 | 8 |
| Beta-lactamase | 0 | 4 | 0 | 10 |
| Beta-lactamase | 0 | 0 | 0 | 9 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 1 | 9 |
| Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 8 |
| euchromatic histone-lysine N-methyltransferase 2 | 24 | 0 | 0 | 24 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 8 |
| Beta-lactamase | 0 | 0 | 0 | 11 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 8 |
| Beta-lactamase | 0 | 4 | 0 | 10 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 16 | 0 | 0 | 16 |
| chromobox protein homolog 1 | 13 | 0 | 0 | 13 |
| thyroid hormone receptor beta isoform 2 | 16 | 0 | 0 | 16 |
| DNA polymerase beta | 4 | 0 | 0 | 4 |
| 60 kDa heat shock protein, mitochondrial | 0 | 6 | 0 | 6 |
| Beta-lactamase OXA-7 | 0 | 0 | 0 | 4 |
| Solute carrier family 15 member 1 | 0 | 12 | 0 | 12 |
| Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
| Spike glycoprotein | 13 | 0 | 0 | 13 |
| 10 kDa heat shock protein, mitochondrial | 0 | 6 | 0 | 6 |
| Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 7 |
| Beta-lactamase | 0 | 1 | 0 | 7 |
| Beta-lactamase | 0 | 1 | 0 | 7 |
| Solute carrier family 15 member 2 | 0 | 5 | 0 | 5 |
| Thiosulfate sulfurtransferase | 0 | 6 | 0 | 6 |
| Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 7 |
| Efflux transporter | 0 | 2 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 8 |
| Beta-lactamase Toho-1 | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 2 | 0 | 3 |
| Class D beta-lactamase | 0 | 1 | 0 | 3 |
| 60 kDa chaperonin | 0 | 6 | 0 | 6 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 7 |
| Solute carrier family 15 member 2 | 0 | 7 | 0 | 8 |
| Beta-lactamase | 0 | 1 | 0 | 9 |
| Beta-lactamase | 0 | 0 | 1 | 5 |
| 10 kDa chaperonin | 0 | 6 | 0 | 6 |
| Metallo-b-lactamase | 0 | 0 | 0 | 13 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 2 | 0 | 11 |
| Histamine H3 receptor | 0 | 0 | 0 | 8 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 1 | 15 |
| Beta-lactamase VIM-1 | 0 | 0 | 0 | 7 |
| Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
| Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 7 | 0 | 0 | 7 |
| 15-lipoxygenase, partial | 8 | 0 | 0 | 8 |
| Microtubule-associated protein tau | 8 | 0 | 0 | 8 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 3 | 0 | 0 | 3 |
| Bloom syndrome protein isoform 1 | 7 | 0 | 0 | 7 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 3 | 0 | 0 | 3 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 2 | 0 | 3 |
| caspase-1 isoform alpha precursor | 4 | 0 | 0 | 4 |
| Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 3 |
| Trypsin | 0 | 1 | 0 | 2 |
| Coagulation factor VII | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| Aromatase | 0 | 4 | 0 | 4 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 8 | 1 | 11 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Calmodulin | 0 | 0 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 4 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 4 | 0 | 4 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 6 | 0 | 7 |
| Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 4 | 0 | 5 |
| Chitotriosidase-1 | 0 | 5 | 2 | 7 |
| Endochitinase B1 | 0 | 5 | 2 | 8 |
| Chitinase A | 0 | 1 | 0 | 1 |
| Chitinase C1 | 0 | 1 | 0 | 1 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 8 | 0 | 0 | 8 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 19 | 0 | 0 | 19 |
| IDH1 | 13 | 0 | 0 | 13 |
| lethal factor (plasmid) | 9 | 0 | 0 | 9 |
| Polyphenol oxidase 2 | 0 | 3 | 0 | 4 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
| hypothetical protein, conserved | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 13 | 0 | 0 | 13 |
| cytochrome P450 2D6 | 8 | 0 | 0 | 8 |
| glucocerebrosidase | 3 | 0 | 0 | 3 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 7 | 0 | 7 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Myeloperoxidase | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 5 | 1 | 6 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 2 | 0 | 2 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 6 | 0 | 7 |
| Adenosine receptor A1 | 0 | 3 | 0 | 5 |
| Adenosine receptor A2a | 0 | 2 | 0 | 5 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 20 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 9 |
| Beta-lactamase | 0 | 3 | 0 | 7 |
| Beta-lactamase | 0 | 0 | 0 | 4 |
| Beta-lactamase | 0 | 2 | 0 | 5 |
| Beta-lactamase | 0 | 1 | 0 | 6 |
| Kappa-type opioid receptor | 0 | 4 | 0 | 12 |
| Penicillin-binding protein 1A | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 7 |
| Beta-lactamase | 0 | 1 | 0 | 6 |
| Beta-lactamase | 0 | 1 | 0 | 7 |
| Beta-lactamase | 0 | 1 | 0 | 6 |
| AmpC | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| BlaVIM-1 | 0 | 1 | 0 | 9 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 6 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 1 | 6 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 1 | 6 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 1 | 6 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 1 | 6 |
| Proton-coupled amino acid transporter 1 | 0 | 3 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 1 | 6 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 1 | 6 |
| pregnane X receptor | 4 | 0 | 0 | 4 |
| progesterone receptor | 12 | 0 | 0 | 12 |
| aryl hydrocarbon receptor | 12 | 0 | 0 | 12 |
| nuclear receptor subfamily 1, group I, member 2 | 5 | 0 | 0 | 5 |
| galanin receptor type 3 | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 8 | 1 | 14 |
| Glycine receptor subunit alpha-1 | 0 | 8 | 0 | 8 |
| Glycine receptor subunit beta | 0 | 8 | 0 | 8 |
| Glycine receptor subunit alpha-2 | 0 | 8 | 0 | 8 |
| Glycine receptor subunit alpha-3 | 0 | 8 | 0 | 8 |
| ORF73 | 0 | 0 | 1 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 6 | 0 | 0 | 6 |
| Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 3 | 0 | 3 | 0 | 4 |
| Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 5 | 0 | 6 |
| Carbonic anhydrase 6 | 0 | 3 | 0 | 4 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 4 | 0 | 5 |
| Carbonic anhydrase 7 | 0 | 3 | 0 | 4 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
| Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 3 | 0 | 4 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 4 |
| Luciferase | 10 | 0 | 0 | 10 |
| Solute carrier family 22 member 6 | 0 | 5 | 0 | 5 |
| Solute carrier family 22 member 8 | 0 | 6 | 0 | 6 |
| Solute carrier family 22 member 11 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 8 | 0 | 4 | 0 | 4 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 9 |
| Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 8 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 5 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 6 |
| Beta-lactamase SHV-1 | 0 | 2 | 0 | 10 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 9 |
| Beta-lactamase TEM | 0 | 3 | 0 | 9 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 6 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 7 |
| Beta-lactamase | 0 | 0 | 0 | 5 |
| Beta-lactamase | 0 | 0 | 0 | 6 |
| Beta-lactamase | 0 | 0 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 7 |
| Beta-lactamase | 0 | 0 | 0 | 8 |
| Albumin | 0 | 1 | 6 | 7 |
| Beta-lactamase SHV-1 | 0 | 1 | 0 | 5 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 6 | 0 | 0 | 6 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 6 | 0 | 0 | 6 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 6 | 0 | 0 | 6 |
| DNA dC->dU-editing enzyme APOBEC-3A isoform a | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 9 | 0 | 0 | 9 |
| Solute carrier family 22 member 8 | 0 | 3 | 0 | 3 |
| Beta-lactamase | 0 | 0 | 0 | 4 |
| Beta-lactamase IMP-1 | 0 | 0 | 0 | 4 |
| Beta-lactamase | 0 | 1 | 0 | 5 |
| Interferon beta | 17 | 0 | 0 | 17 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| PAX8 | 0 | 0 | 0 | 2 |
| SMAD family member 2 | 7 | 0 | 0 | 7 |
| SMAD family member 3 | 7 | 0 | 0 | 7 |
| caspase 7, apoptosis-related cysteine protease | 6 | 0 | 0 | 6 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 8 | 0 | 0 | 8 |
| PINK1 | 2 | 0 | 0 | 2 |
| estrogen receptor 2 (ER beta) | 7 | 0 | 0 | 7 |
| G | 13 | 0 | 0 | 13 |
| 67.9K protein | 7 | 0 | 0 | 7 |
| Parkin | 5 | 0 | 0 | 5 |
| peroxisome proliferator activated receptor gamma | 13 | 0 | 0 | 13 |
| heat shock protein 90 | 0 | 0 | 2 | 2 |
| caspase-3 | 6 | 0 | 0 | 6 |
| calcineurin A1, putative | 0 | 0 | 1 | 1 |
| thyroid stimulating hormone receptor | 12 | 0 | 0 | 12 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 8 | 0 | 0 | 8 |
| cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
| hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
| cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9 precursor | 7 | 0 | 0 | 7 |
| perilipin-5 | 0 | 1 | 0 | 1 |
| perilipin-1 | 0 | 1 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| huntingtin isoform 2 | 4 | 0 | 0 | 4 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 1 | 3 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| melanocortin receptor 4 | 0 | 1 | 0 | 1 |
| CAAX prenyl protease | 0 | 0 | 0 | 2 |
| bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
| glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 2 |
| hexokinase HKDC1 | 0 | 1 | 0 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| Synaptojanin-2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 5 | 0 | 6 |
| Synaptojanin-1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 3 |
| Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
| HLA class I histocompatibility antigen, B alpha chain | 13 | 0 | 0 | 13 |
| Cellular tumor antigen p53 | 15 | 0 | 0 | 15 |
| 72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
| Trypanothione reductase | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 3 | 1 | 0 | 4 |
| Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 3 | 0 | 0 | 3 |
| Inositol hexakisphosphate kinase 1 | 13 | 0 | 0 | 13 |
| Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
| ATPase family AAA domain-containing protein 5 | 8 | 0 | 0 | 8 |
| Ataxin-2 | 9 | 0 | 0 | 9 |
| Spermine oxidase | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 13 | 0 | 0 | 13 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 3 | 0 | 4 |
| Chain A, Ferritin light chain | 7 | 0 | 0 | 7 |
| Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Dipeptidase 1 | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 2 | 0 | 2 |
| DNA gyrase subunit A | 0 | 2 | 0 | 2 |
| DNA gyrase subunit B | 0 | 2 | 0 | 4 |
| DNA gyrase subunit A | 0 | 7 | 0 | 11 |
| DNA gyrase subunit B | 0 | 7 | 0 | 11 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
| DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 3 |
| DNA topoisomerase 4 subunit A | 0 | 4 | 0 | 6 |
| DNA topoisomerase 2-alpha | 0 | 2 | 1 | 13 |
| DNA gyrase subunit A | 0 | 2 | 0 | 4 |
| Multidrug resistance protein MdtK | 0 | 0 | 2 | 2 |
| DNA gyrase subunit B | 0 | 5 | 0 | 7 |
| DNA gyrase subunit A | 0 | 7 | 0 | 9 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 3 | 0 | 4 |
| DNA topoisomerase 4 subunit A | 0 | 2 | 0 | 2 |
| DNA topoisomerase 4 subunit B | 0 | 2 | 0 | 2 |
| Integrase | 0 | 3 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 7 | 0 | 7 |
| Neutrophil elastase | 0 | 2 | 0 | 2 |
| Beta-lactamase OXA-1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 2 | 1 | 3 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 2 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
| Dihydroorotate dehydrogenase (quinone), mitochondrial | 0 | 1 | 0 | 1 |
| endonuclease IV | 3 | 0 | 0 | 3 |
| ATAD5 protein, partial | 5 | 0 | 0 | 5 |
| Fumarate hydratase | 5 | 0 | 0 | 5 |
| PPM1D protein | 3 | 0 | 0 | 3 |
| Thrombopoietin | 2 | 0 | 0 | 2 |
| polyprotein | 5 | 0 | 0 | 5 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
| ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
| steroidogenic factor 1 | 0 | 1 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 7 | 0 | 0 | 7 |
| neuropeptide S receptor isoform A | 3 | 0 | 0 | 3 |
| Tubulin alpha-1A chain | 0 | 2 | 1 | 3 |
| Tubulin beta chain | 0 | 2 | 1 | 3 |
| Plasma kallikrein | 0 | 0 | 0 | 2 |
| Tubulin beta-4A chain | 0 | 3 | 2 | 6 |
| ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 5 |
| Tubulin beta chain | 0 | 3 | 2 | 6 |
| Tubulin alpha-3C chain | 0 | 3 | 2 | 6 |
| Serine/threonine-protein kinase pim-1 | 0 | 2 | 0 | 3 |
| ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 5 |
| Tubulin alpha-1B chain | 0 | 3 | 2 | 6 |
| Tubulin alpha-4A chain | 0 | 3 | 2 | 6 |
| Tubulin beta-4B chain | 0 | 3 | 2 | 6 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Tubulin beta-3 chain | 0 | 3 | 2 | 6 |
| Tubulin beta-2A chain | 0 | 3 | 2 | 6 |
| Tubulin polymerization-promoting protein | 0 | 0 | 1 | 1 |
| Tubulin beta-8 chain | 0 | 3 | 2 | 6 |
| Tubulin beta-2B chain | 0 | 4 | 0 | 4 |
| Tubulin alpha-3E chain | 0 | 3 | 2 | 6 |
| Tubulin alpha-1A chain | 0 | 3 | 2 | 6 |
| Similar to alpha-tubulin isoform 1 | 0 | 3 | 0 | 3 |
| Similar to alpha-tubulin isoform 1 | 0 | 3 | 0 | 3 |
| CREB-binding protein | 2 | 0 | 0 | 2 |
| Tubulin alpha-1C chain | 0 | 3 | 2 | 6 |
| Tubulin beta-6 chain | 0 | 3 | 2 | 6 |
| Tubulin beta-2B chain | 0 | 3 | 2 | 6 |
| Tubulin beta-1 chain | 0 | 3 | 2 | 6 |
| 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
| Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium/glucose cotransporter 1 | 0 | 0 | 1 | 1 |
| Sodium/glucose cotransporter 2 | 0 | 1 | 1 | 2 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
| Motilin receptor | 0 | 0 | 1 | 1 |
| low molecular weight phosphotyrosine protein phosphatase isoform c | 0 | 1 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 6 | 6 |
| Motilin receptor | 0 | 1 | 1 | 2 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| 30S ribosomal protein S6 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S7 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L15 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L10 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L11 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L7/L12 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L19 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L1 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L20 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L27 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L28 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L29 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L31 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L31 type B | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L32 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L33 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L34 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L35 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L36 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S10 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S11 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S12 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S13 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S16 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S18 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S19 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S20 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S2 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S3 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S4 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S5 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S8 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S9 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L13 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L14 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L16 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L23 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S15 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L17 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L21 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L30 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L6 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S14 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S17 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S1 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L18 | 0 | 2 | 1 | 3 |
| Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 4 | 0 | 4 |
| 50S ribosomal protein L2 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L3 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L24 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L4 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L22 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L5 | 0 | 2 | 1 | 3 |
| 30S ribosomal protein S21 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L25 | 0 | 2 | 1 | 3 |
| 50S ribosomal protein L36 2 | 0 | 2 | 1 | 3 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 1 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 2 | 0 | 3 |
| Regulatory protein E2 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
| DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| DNA topoisomerase 2-beta | 0 | 1 | 1 | 8 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 4 | 4 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 3 | 0 | 4 |
| Delta-type opioid receptor | 0 | 4 | 1 | 6 |
| Mu-type opioid receptor | 0 | 4 | 2 | 9 |
| Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
| Histamine H1 receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 5 | 3 | 9 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 5 | 1 | 7 |
| Kappa-type opioid receptor | 0 | 5 | 2 | 8 |
| Mu-type opioid receptor | 0 | 3 | 1 | 6 |
| Mu-type opioid receptor | 0 | 5 | 0 | 5 |
| Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
| Chain B, Cell division protein kinase 6 | 0 | 1 | 0 | 1 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
| G2/mitotic-specific cyclin-B2 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Alpha-amylase 1A | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Casein kinase II subunit alpha' | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 3 | 0 | 3 |
| Cruzipain | 0 | 1 | 0 | 1 |
| Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase SYK | 0 | 1 | 1 | 2 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 alpha | 0 | 1 | 0 | 1 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Casein kinase II subunit beta | 0 | 2 | 0 | 2 |
| Casein kinase II subunit alpha | 0 | 2 | 0 | 2 |
| Inositol monophosphatase 1 | 5 | 0 | 0 | 5 |
| Cyclin-dependent kinase 6 | 0 | 1 | 0 | 1 |
| Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
| Cyclin homolog | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha 3 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B3 | 0 | 1 | 0 | 1 |
| Enoyl-acyl-carrier protein reductase | 0 | 3 | 0 | 3 |
| 3-oxoacyl-acyl-carrier protein reductase | 0 | 1 | 0 | 1 |
| Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 3 | 0 | 0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-4 | 2 | 1 | 0 | 3 |
| Neuronal acetylcholine receptor subunit beta-2 | 2 | 1 | 0 | 3 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| UDP-N-acetylglucosamine 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
| UDP-N-acetylglucosamine 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
| Beta-galactosidase | 0 | 1 | 0 | 1 |
| Lipopolysaccharide heptosyltransferase 1 | 0 | 1 | 0 | 1 |
| PA-I galactophilic lectin | 0 | 0 | 1 | 1 |
| Jacalin | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| NH(3)-dependent NAD(+) synthetase | 0 | 2 | 0 | 2 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| Asialoglycoprotein receptor 1 | 0 | 1 | 1 | 2 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 3 | 0 | 3 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
| Protein arginine N-methyltransferase 5 | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
| Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
| Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
| arylsulfatase A | 5 | 0 | 0 | 5 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
| Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 3 | 0 | 3 |
| Intestinal-type alkaline phosphatase | 0 | 2 | 0 | 2 |
| Phospholipase A-2-activating protein | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| CAAX prenyl protease 2 isoform 2 | 0 | 0 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
| DNA primase | 0 | 1 | 0 | 1 |
| Type-1A angiotensin II receptor | 0 | 1 | 0 | 1 |
| Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 2 | 0 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Alpha-mannosidase 2C1 | 0 | 1 | 0 | 1 |
| Fucose-binding lectin PA-IIL | 0 | 1 | 0 | 1 |
| CD209 antigen | 0 | 1 | 0 | 1 |
| ClpP | 2 | 0 | 0 | 2 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 4 | 0 | 0 | 4 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| glucokinase regulatory protein | 2 | 0 | 0 | 2 |
| serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 4 | 1 | 5 |
| Solute carrier family 22 member 1 | 0 | 0 | 0 | 1 |
| Thioredoxin reductase | 0 | 1 | 0 | 1 |
| Flavodoxin | 0 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 4 | 0 | 4 |
| Stromelysin-1 | 0 | 1 | 1 | 2 |
| Matrilysin | 0 | 1 | 0 | 1 |
| Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 0 | 1 | 1 |
| Histidine decarboxylase | 0 | 0 | 1 | 1 |
| Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 3 | 0 | 3 |
| Replicase polyprotein 1ab | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Chain A, Isoleucyl-tRNA synthetase | 0 | 1 | 0 | 1 |
| twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 2 |
| Isoleucine--tRNA ligase | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 1 | 1 |
| L-cysteine:1D-myo-inositol 2-amino-2-deoxy-alpha-D-glucopyranoside ligase | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 1 |
| Sialidase-4 | 0 | 1 | 0 | 1 |
| Sialidase-1 | 0 | 1 | 0 | 1 |
| Sialidase-3 | 0 | 1 | 0 | 1 |
| Sialidase-2 | 0 | 1 | 0 | 1 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| caspase-3 | 2 | 0 | 0 | 2 |
| STE24 | 0 | 0 | 0 | 1 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
| rac GTPase-activating protein 1 isoform a | 0 | 1 | 0 | 1 |
| Vpr | 3 | 0 | 0 | 3 |
| Serine/threonine-protein kinase D3 | 0 | 0 | 1 | 2 |
| Phospholipase A2, major isoenzyme | 0 | 0 | 0 | 1 |
| Protein kinase C gamma type | 0 | 1 | 1 | 3 |
| Protein kinase C beta type | 0 | 1 | 1 | 3 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 3 | 0 | 4 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 2 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 1 | 2 | 4 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
| Protein kinase C eta type | 0 | 0 | 1 | 2 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Protein kinase C iota type | 0 | 0 | 1 | 2 |
| Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
| Protein kinase C epsilon type | 0 | 1 | 1 | 3 |
| Protein kinase C theta type | 0 | 0 | 1 | 2 |
| Protein kinase C zeta type | 0 | 0 | 1 | 2 |
| Protein kinase C delta type | 0 | 1 | 1 | 3 |
| Serine/threonine-protein kinase D1 | 0 | 0 | 1 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Estrogen receptor 1 | 0 | 1 | 0 | 1 |
| fMet-Leu-Phe receptor | 0 | 1 | 0 | 1 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| Cyclooxygenase-2 | 0 | 1 | 0 | 1 |
| GALC protein | 1 | 0 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 2 |
| Sterol 14-alpha-demethylase | 0 | 0 | 2 | 2 |
| 14-alpha sterol demethylase | 0 | 0 | 2 | 2 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 2 | 2 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
| Sterol 14-alpha demethylase | 0 | 0 | 2 | 2 |
| Sterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
| 14-alpha sterol demethylase | 0 | 0 | 2 | 2 |
| 14-alpha sterol demethylase | 0 | 0 | 2 | 2 |
| luciferase | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 3 | 0 | 3 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| Low molecular weight protein-tyrosine phosphatase A | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
| Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| BRCA1 | 1 | 0 | 0 | 1 |
| P53 | 1 | 0 | 0 | 1 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| M18 aspartyl aminopeptidase | 0 | 1 | 0 | 1 |
| cathepsin L1 | 0 | 1 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
| FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
| Vif | 0 | 1 | 0 | 1 |
| transcription factor p65 isoform 1 | 0 | 0 | 1 | 1 |
| serine/threonine-protein kinase 33 isoform a | 0 | 0 | 1 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| Aryl hydrocarbon receptor | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 2 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 1 | 2 |
| Tyrosine-protein kinase ABL1 | 0 | 1 | 0 | 2 |
| Myc proto-oncogene protein | 0 | 1 | 0 | 2 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
| Amyloid-beta precursor protein | 0 | 1 | 1 | 2 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Cathepsin D | 0 | 1 | 0 | 1 |
| Luciferin 4-monooxygenase | 0 | 1 | 1 | 2 |
| DNA polymerase alpha catalytic subunit | 0 | 1 | 0 | 1 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Breakpoint cluster region protein | 0 | 1 | 0 | 2 |
| Tyrosinase | 0 | 3 | 0 | 3 |
| Ornithine decarboxylase | 0 | 1 | 0 | 1 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 1 | 3 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 2 | 0 | 4 |
| 5-hydroxytryptamine receptor 1A | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 1 | 2 |
| Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
| Endothelin receptor type B | 1 | 0 | 0 | 1 |
| Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 1 | 0 | 0 | 1 |
| ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| Alpha-glucosidase MAL12 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Transcription factor p65 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 3 |
| Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 1 | 2 |
| N1L | 0 | 1 | 0 | 1 |
| NAD(P)H dehydrogenase [quinone] 1 | 0 | 0 | 0 | 3 |
| Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-2 | 0 | 0 | 1 | 1 |
| NAD-dependent protein deacetylase sirtuin-1 | 0 | 0 | 1 | 3 |
| Prenyltransferase homolog | 0 | 0 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 0 | 1 | 1 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| large T antigen | 0 | 1 | 0 | 1 |
| Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
| Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| Chain H, Immunoglobulin Igg1 Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Immunoglobulin Igg1 Lambda Light Chain | 0 | 0 | 1 | 1 |
| Chain A, DODECIN | 0 | 0 | 1 | 1 |
| Chain A, DODECIN | 0 | 0 | 1 | 1 |
| Chain C, DODECIN | 0 | 0 | 1 | 1 |
| Chain E, DODECIN | 0 | 0 | 1 | 1 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| Riboflavin-binding protein | 0 | 1 | 1 | 2 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 1 |
| Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Plasminogen | 0 | 1 | 0 | 1 |
| Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Trypsin-2 | 0 | 1 | 0 | 1 |
| Lysosomal protective protein | 0 | 1 | 0 | 1 |
| Chymase | 0 | 1 | 0 | 1 |
| Trypsin-3 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 2 | 0 | 2 | 0 | 2 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| Ras guanyl-releasing protein 3 | 0 | 0 | 1 | 1 |
| Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 2 | 5 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A1 | 0 | 2 | 1 | 5 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 2 | 0 | 2 |
| Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 0 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
| Protein Rev | 0 | 0 | 1 | 1 |
| Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
| Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
| Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
| Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
| Chain A, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
| Chain C, enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
| Chain A, Repressor | 0 | 0 | 1 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
| Endoplasmic reticulum chaperone BiP | 0 | 1 | 0 | 1 |
| Carbonyl reductase [NADPH] 1 | 0 | 2 | 0 | 2 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | 0 | 2 | 0 | 2 |
| Enoyl-acyl carrier reductase | 0 | 1 | 0 | 1 |
| Enoyl-ACP reductase II | 0 | 1 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 9 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase IV | 0 | 2 | 0 | 2 |
| Kynurenine 3-monooxygenase | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Prolyl endopeptidase FAP | 0 | 1 | 0 | 1 |
| Prolyl endopeptidase FAP | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 8 | 0 | 2 | 0 | 2 |
| Dipeptidyl peptidase 9 | 0 | 2 | 0 | 2 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 0 | 1 | 1 |
| Cytochrome P450 144 | 0 | 0 | 1 | 1 |
| Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
| Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
| Cholesterol 24-hydroxylase | 0 | 2 | 1 | 3 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |